Abstract
Pyrrolo[1,4]benzodiazepines (PBDs) are a growing group of microbial secondary metabolites that showed remarkable biological activities particularly against tumor cells. Their antitumor activity is mainly due to their specifically binding to DNA and other polydeoxynucleotides to form irreversibly polymer-bound drugs. Consequently, they have been the target of several syntheses as well as screening of natural sources to discover new members. This review provides an update on recent discoveries of PBDs as well as a compilation of spectroscopic data described in the literature.
Keywords: Pyrrolo[1,4]benzodiazepines (PBDs), biological activity, natural products
Mini-Reviews in Organic Chemistry
Title: Naturally Occuring Pyrrolo[1,4]benzodiazepines in Bacteria
Volume: 7 Issue: 1
Author(s): Serge Fotso
Affiliation:
Keywords: Pyrrolo[1,4]benzodiazepines (PBDs), biological activity, natural products
Abstract: Pyrrolo[1,4]benzodiazepines (PBDs) are a growing group of microbial secondary metabolites that showed remarkable biological activities particularly against tumor cells. Their antitumor activity is mainly due to their specifically binding to DNA and other polydeoxynucleotides to form irreversibly polymer-bound drugs. Consequently, they have been the target of several syntheses as well as screening of natural sources to discover new members. This review provides an update on recent discoveries of PBDs as well as a compilation of spectroscopic data described in the literature.
Export Options
About this article
Cite this article as:
Fotso Serge, Naturally Occuring Pyrrolo[1,4]benzodiazepines in Bacteria, Mini-Reviews in Organic Chemistry 2010; 7 (1) . https://dx.doi.org/10.2174/1570193X11007010068
DOI https://dx.doi.org/10.2174/1570193X11007010068 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interleukin-24: A Molecule with Potential Anti-Cancer Activity and a Cytokine in Search of a Function
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Targeting of Aberrant Transcription Factors in Leukemia: Strategies for RUNX1/ETO
Current Drug Targets Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Engineered Peptides for Applications in Cancer-Targeted Drug Delivery and Tumor Detection
Mini-Reviews in Medicinal Chemistry Drug Repurposing for the Treatment of Staphylococcal Infections
Current Pharmaceutical Design Therapeutic Perspectives for cN-II in Cancer.
Current Medicinal Chemistry MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics Personalized Medicine in a Consumer Age
Current Pharmacogenomics and Personalized Medicine Molecular Foundations for Personalized Therapy in Prostate Cancer
Current Drug Targets Molecular and Cellular Pathways as Treatment Targets for Biologic Therapies in Systemic Sclerosis
Current Medicinal Chemistry Signal Transduction Therapy for Cancer - Whither Now?
Current Signal Transduction Therapy Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Mini-Reviews in Organic Chemistry A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in Xenografts
Anti-Cancer Agents in Medicinal Chemistry DYRK1A Kinase Inhibitors with Emphasis on Cancer
Mini-Reviews in Medicinal Chemistry Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes
Current Pharmaceutical Design Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs Development and Application of Fourier-Transform Infrared Chemical Imaging of Tumour in Human Tissue
Current Medicinal Chemistry Overview: Translating Hsp90 Biology into Hsp90 Drugs
Current Cancer Drug Targets Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Current Cancer Drug Targets